Nabla vs Doctolib: head-to-head for French practices (2026)

A French doctor choosing an AI scribe is, unusually, often choosing between two French companies. Nabla — founded in Paris and our 2026 Editor's Pick — is a documentation-first copilot. Doctolib is the dominant French booking platform, now shipping its own AI tools inside that platform.

They're not really the same product, and the right pick turns less on a feature list than on a structural question: how committed is your practice to the Doctolib ecosystem?

This is our 2026 head-to-head — sourced facts from each vendor's published material, plus our hands-on testing of Nabla. Doctolib is provisional in our catalog — we have not hands-on tested it — so treat its side as a shortlisting aid.

At a glance

	Nabla	Doctolib
Our editorial score	9.0 / 10 (Editor's Pick, tested)	Provisional — not yet hands-on tested
HQ	Paris, France / Brooklyn, USA	Paris, France
What it is	Documentation-first ambient copilot	AI tools inside the Doctolib platform
Compliance	HIPAA + SOC 2 Type II + GDPR + ISO 27001	GDPR + EU hosting
Works inside Doctolib	No — Doctolib's ecosystem is closed	Native (it is Doctolib)
Free entry	Free tier — 30 consults/mo	Bundled with the Doctolib subscription
Pro pricing	~US$120/mo (public pricing page offline as of May 2026)	Bundled; AI phone assistant €99/mo incl. VAT
Scope	Transcribe, fill the patient file, draft prescriptions	Booking + patient journey, with documentation as one feature

The ecosystem question comes first

In most countries you pick a scribe on merit. In France there's a structural fact to settle first: Doctolib has closed its ecosystem. A practice that runs scheduling and the patient journey on Doctolib is steered toward Doctolib's own AI assistant — and a competing copilot like Nabla cannot plug into Doctolib.

That doesn't make the decision for you, but it frames it:

• If your practice lives inside Doctolib and you want your AI in the same place as your scheduling, Doctolib's Consultation Assistant is the low-friction choice — it's already there.
• If you're willing to run a separate copilot, or you're not committed to Doctolib, Nabla is an open documentation tool that works alongside whatever else you use — and it's the stronger product on the things a scribe is actually judged on.

Be honest with yourself about which of those you are before comparing features, because it narrows the field more than any spec does.

Note quality and verification

Here the two are not comparable on the same footing, and we'll say so plainly. Nabla is hands-on tested — 9.0 clinical precision, 8.9 note quality in our rubric, the strongest hands-on results in the category, which is why it's our Editor's Pick. Doctolib's Consultation Assistant is provisional — we have not hands-on tested it, so we can't put a verified note-quality number against it.

What we can say: Nabla is a documentation-first product — transcription, patient-file population and prescription drafting are the whole point of it, and it's been refined accordingly. Doctolib's AI is one feature of a booking-and-patient-journey platform. That difference in focus tends to show up in note depth, though you should verify it yourself by trialling both on real consultations.

Compliance and French hosting

Nabla ships the full HIPAA + SOC 2 Type II + GDPR + ISO 27001 quartet — the only tested tool in our catalog to enumerate all four — with no audio stored by default. As a French company it is close to the French regulatory frame.

Doctolib is a long-established French healthcare-data company; GDPR and EU hosting are a given, and its scale in French healthcare means its data posture is mature. For either vendor, the French-specific question to put in writing is HDS — certified health-data hosting — which a generic GDPR statement does not cover. See our compliance checklist, which generalises to HDS.

Pricing

Nabla offers a real free tier (30 consultations/month) — a genuine multi-week evaluation. Its Pro pricing is reported around US$120/month, but the public pricing page is offline as of May 2026, so confirm with the vendor.

Doctolib bundles the Consultation Assistant into the broader Doctolib platform subscription rather than itemising it; its AI telephone assistant is separately priced at €99/month incl. VAT. If you're already a Doctolib customer the bundled model is simple; if you're not, you can't price the assistant standalone.

Who should choose which

Choose Nabla if:

• Note quality is your primary requirement — it's the tested, Editor's-Pick option.
• You want a documentation-first copilot: transcription, patient-file population, prescription drafting.
• You want the full compliance quartet and an open tool not tied to one platform.
• You're not committed to running everything inside Doctolib.

Choose Doctolib's AI if:

• Your practice already runs scheduling and the patient journey on Doctolib.
• You want your AI assistant in the same place as the rest of your workflow.
• An AI telephone assistant is a priority (Doctolib's is explicit, at €99/mo).
• You accept it as a patient-journey platform with documentation as one feature.

Bottom line

Two French companies, two genuinely different products. Nabla is the stronger scribe — tested, our Editor's Pick, documentation-first, with the full compliance quartet — and the right choice for a French doctor who weights note quality and isn't locked into one platform. Doctolib's AI is the natural pick if your practice already lives on Doctolib, where its already-in-the-platform position outweighs the fact that it's provisional and untested by us.

Settle the ecosystem question first, confirm HDS hosting, then trial. For the wider field see our best AI scribes for doctors in France guide, the Nabla review and the Doctolib review.